Survey of patient and partner satisfaction following collagenase Clostridium histolyticum treatment for Peyronie's disease.


Intralesional injection of collagenase Clostridium histolyticum (CCH) is a minimally invasive, Food and Drug Administration-approved, effective treatment for Peyronie's disease (PD). To assess the satisfaction of patients and their female sexual partners (FSP) following CCH therapy for PD, we conducted a retrospective review of the records of all patients… (More)
DOI: 10.1111/andr.12302


4 Figures and Tables